158 related articles for article (PubMed ID: 3034708)
1. Multiple variants in foot-and-mouse disease virus (FMDV) populations: the Achilles heel for peptide and rec. DNA vaccines?
Barteling SJ; Woortmeyer R
Dev Biol Stand; 1987; 66():511-21. PubMed ID: 3034708
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodies.
Borca MV; Garmendia AE; Baxt B; Moore DM; Srikumaran S; Morgan DO
Immunology; 1993 Jul; 79(3):368-74. PubMed ID: 8406565
[TBL] [Abstract][Full Text] [Related]
3. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
5. Host cell selection of antigenic variants of foot-and-mouth disease virus.
Bolwell C; Brown AL; Barnett PV; Campbell RO; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
J Gen Virol; 1989 Jan; 70 ( Pt 1)():45-57. PubMed ID: 2471782
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
[TBL] [Abstract][Full Text] [Related]
7. Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22.
Bolwell C; Parry NR; Rowlands DJ
J Gen Virol; 1992 Mar; 73 ( Pt 3)():727-31. PubMed ID: 1312129
[TBL] [Abstract][Full Text] [Related]
8. Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes.
Garmendia AE; Borca MV; Morgan DO; Baxt B
J Immunol; 1989 Nov; 143(9):3015-9. PubMed ID: 2553817
[TBL] [Abstract][Full Text] [Related]
9. Serological prospects for peptide vaccines against foot-and-mouth disease virus.
Parry NR; Ouldridge EJ; Barnett PV; Clarke BE; Francis MJ; Fox JD; Rowlands DJ; Brown F
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2919-30. PubMed ID: 2479714
[TBL] [Abstract][Full Text] [Related]
10. Synthetic peptide vaccines: foot-and-mouth disease virus as a model.
Sobrino F; Blanco E; García-Briones M; Ley V
Dev Biol Stand; 1999; 101():39-43. PubMed ID: 10566773
[TBL] [Abstract][Full Text] [Related]
11. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
Das BR; Pattnaik B; Venkataramanan R; Rai DV
Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
13. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants.
Francis MJ; Hastings GZ; Syred AD; McGinn B; Brown F; Rowlands DJ
Nature; 1987 Nov 12-18; 330(6144):168-70. PubMed ID: 2444892
[TBL] [Abstract][Full Text] [Related]
14. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
15. Synthetic peptide vaccines: unexpected fulfillment of discarded hope?
Meloen RH; Langeveld JP; Schaaper WM; Slootstra JW
Biologicals; 2001; 29(3-4):233-6. PubMed ID: 11851321
[TBL] [Abstract][Full Text] [Related]
16. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
17. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
Parry NR; Syred A; Rowlands DJ; Brown F
Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
[TBL] [Abstract][Full Text] [Related]
18. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
Stave JW; Card JL; Morgan DO
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
[TBL] [Abstract][Full Text] [Related]
19. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1.
Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F
Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534
[TBL] [Abstract][Full Text] [Related]
20. Recognition of B and T cell epitopes by cattle immunized with a synthetic peptide containing the major immunogenic site of VP1 FMDV 01 Campos.
Zamorano P; Wigdorovitz A; Chaher MT; Fernandez FM; Carrillo C; Marcovecchio FE; Sadir AM; Borca MV
Virology; 1994 Jun; 201(2):383-7. PubMed ID: 8184548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
